← Leaderboards
Richelle C Charles
Massachusetts General Hospital
$6,402,547
Attributed
$9,501,135
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,501,135 · 5
By mechanism
R01$8,383,418 · 3
K08$684,478 · 1
R21$433,239 · 1
Top collaborators
- Jason B Harris5 shared
- Jason Randolph Andrews4 shared
- Jacob John2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jason B Harris$16,544,490
- Amit Dolar Joshi$1,127,845
- Edward T. Ryan$44,052,519
- Jason Randolph Andrews$8,284,933
- Joel S. Weissman$10,911,478
Others in their field
Top investigators on “Antigens”
- Barton F Haynes · Duke University$488,918,563
- Lawrence Corey · Fred Hutchinson Cancer Center$325,880,100
- Dennis R. Burton · Scripps Research Institute$291,395,948
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$245,204,950
- Jeffrey P Krischer · University Of South Florida$208,289,343
- Dan H. Barouch · Fred Hutchinson Cancer Center$124,506,327
Research focus
AntigensCessation Of LifeInfectionResponseVaccinesAntibodiesProgramsAreaVaccinationBangladeshSerotypingCountryCohortCharacteristicsSpecificitySamplingEnteralSerumBasePathogenAntibody ResponseDiagnosticMemory B-LymphocyteAffect
Grant awards (19)
Novel tools for measuring typhoid vaccine impact$667,635
R01 · FY2025 · AI
Novel tools for measuring typhoid vaccine impact$756,045
R01 · FY2024 · AI
Antibody mediated protective immunity against cholera$725,518
R01 · FY2022 · AI
Detection of asymptomatic Salmonella enterica serotype Typhi and Paratyphi A carriage by serum antibodies targeting YncE$530,387
R01 · FY2022 · AI · contact PI
Evaluation of a point-of-care immunochromatographic assay for enteric fever$141,776
R21 · FY2022 · AI · contact PI
Antibody mediated protective immunity against cholera$757,955
R01 · FY2021 · AI
Detection of asymptomatic Salmonella enterica serotype Typhi and Paratyphi A carriage by serum antibodies targeting YncE$542,437
R01 · FY2021 · AI · contact PI
Evaluation of a point-of-care immunochromatographic assay for enteric fever$291,463
R21 · FY2021 · AI · contact PI
Antibody mediated protective immunity against cholera$770,722
R01 · FY2020 · AI
Detection of asymptomatic Salmonella enterica serotype Typhi and Paratyphi A carriage by serum antibodies targeting YncE$621,384
R01 · FY2020 · AI · contact PI
Antibody mediated protective immunity against cholera$772,046
R01 · FY2019 · AI
Detection of asymptomatic Salmonella enterica serotype Typhi and Paratyphi A carriage by serum antibodies targeting YncE$669,518
R01 · FY2019 · AI · contact PI
Antibody mediated protective immunity against cholera$839,456
R01 · FY2018 · AI
Detection of asymptomatic Salmonella enterica serotype Typhi and Paratyphi A carriage by serum antibodies targeting YncE$730,315
R01 · FY2018 · AI · contact PI
High-throughput proteomic study of protective immunity in human cholera infection$137,160
K08 · FY2014 · AI · contact PI
High-throughput proteomic study of protective immunity in human cholera infection$137,160
K08 · FY2013 · AI · contact PI
High-throughput proteomic study of protective immunity in human cholera infection$137,160
K08 · FY2012 · AI · contact PI
High-throughput proteomic study of protective immunity in human cholera infection$136,680
K08 · FY2011 · AI · contact PI
High-throughput proteomic study of protective immunity in human cholera infection$136,318
K08 · FY2010 · AI · contact PI